|
Spring 2005
Highlights from the 12th Conference on Retroviruses and Opportunistic Infections
by Dr. Marjan Hezareh
& Metabolic Disorders Secondary to HIV Infection and Antiretroviral Treatment - Part II
by Dr. Stephen J. Brown
ARA's Director of Scientific Communications Marjan Hezarah, Ph.D. reviews the latest scientific, therapeutic and clinical data presented at the 12th Conference on Retroviruses and Opportunistic Infections, held in Boston, Massachusetts in Februarry, 2005. ARA's Medical Director Stephen J. Brown, M.D. reviews some of the latest studies and recommendations to prevent and treat HIV-related metabolic disorders, including lipodystrophy, in this second installment of a two-part series. We provide an update on our progress in developing the antiviral prostratin.
Fall
2004
Highlights
from the XVth International AIDS Conference in Bangkok
by Dr. Stephen J. Brown
& Is Injectable Silicone a Safe and Effective Treatment
of HIV-associated Facial Lipoatrophy?
by Dr. Marjan Hezareh
ARA's Director of Scientific Communications Marjan Hezarah, Ph.D. reviews and compares various treatment options for the correction of facial lipoatrophy to the latest results obtained on the safety and efficacy of treatment with microdroplet silicone injections.ARA's Medical Director Stephen
J. Brown, M.D. reviews in this short report the latest
scientific, therapeutic and clinical data presented
at the XVth International AIDS Conference (July, 2004)
held in Bangkok, Thailand. ARA's Director of Scientific
Communications Marjan Hezarah, Ph.D. reviews and compares
various treatment options for the correction of facial
lipoatrophy to the latest results obtained on the safety
and efficacy of treatment with microdroplet silicone
injections. We
provide an update on our progress in developing the
antiviral prostratin.
Spring
2004
Metabolic
Disorders Associated with HIV and its Treatment Part
I: Lipodystrophy, Etiology, Relationship to HAART and
HAART Regimen Considerations
by Stephen J. Brown, M.D.
ARA's Medical Director Stephen
J. Brown, M.D. discusses HIV-related lipodystrophy,
excercise specialist Noah Manne discusses the importance
of diet and exercise for the immune-compromised, and
ARA's Director of Scientific Communications Marjan Hezarah,
Ph.D. takes a look at some of the briefs from the 11th
Conference on Retroviruses and Opportunistic Infections.
A new study being conducted at ARA is also announced.
We
provide an update on our progress in developing the
antiviral prostratin.
Summer
2003
HIV-related
Peripheral Neuropathy:
Diagnosis and Treatment
by Seymour Young, M.D.
Noted neurologist and member of
ARA's Institutional Review Board Seymour Young, M.D.
discusses HIV-related peripheral neuropathy. ARA's Director
of Scientific Communications Marjan Hezarah, Ph.D. looks
at results in some recent HIV/AIDS studies. Four new
studies being conducted at ARA are also announced.
We
provide an update on our progress in developing the
antiviral prostratin.
Spring
2003
New
and Promising Drugs in Devlopment Versus Rising Number
of New HIV Infections in U.S.
by Marjan Hezareh, Ph.D.
ARA's Director Of Scientific Communications discusses
information from the 10th Conference on Retroviruses
and Opportunistic Infections In Boston. Marjan also
looks at “RNA Interference: A New Tool in the Fight
against HIV/AIDS.” Thrree new studies being conducted
at ARA are announced. We
provide an update on our progress in developing the
antiviral prostratin.
Fall
2002
HIV RESERVOIR ISSUE
HIV-1:
The Nature of Viral Reservoirs
by Robert Siliciano, M.D., Ph.D.—
Robert Siliciano of John Hopkins University discusses
the significance of viral reservoirs in eradicating
HIV and assesses the likelihood of cleaning out or "flushing"
these reservoirs. ARA's Searchlight Editor Marjan Hezareh
discusses reservoirs and also gives us her report on
the 2002 XIV International AIDS Conference in Barcelona.
We
provide an update on our progress in developing the
antiviral prostratin.
Spring
2002
HIV OVERVIEW ISSUE
HIV-1:
Two Decades of Clinical and Scientific Advances
by Marjan Hezareh, Ph.D.—
ARA's Searchlight Editor Marjan Hezareh, Ph.D. looks at
twenty years of HIV/AIDS research and drug development,
assesses where we are now, and takes a look at some new
antiviral drugs in the pipeline.
Whole
Story
Fall
2001
VACCINE & PREVENTION ISSUE
A
Boosted Hope:
AIDS Vaccine Research
by Marjan Hezareh, Ph.D.—
ARA's new Director of Scientific Communications and
Searchlight Editor Marjan Hezareh, Ph.D. looks at the
challenges faced by the scientific community in developing
an effective HIV/AIDS vaccine. Marjan also reports on
vaccine developments reported at the March Keystone
Conference and the recent "AIDS Vaccine 2000"
Symposium in Philadelphia.
Whole
story
Spring
2001
Prostratin:
A Potential Adjuvant Therapy for HAART Against HIV-1
Reservoirs
by Stephen J. Brown, M.D.—
ARA's Director of Clinical Research looks at the unique
anti-HIV properties of prostratin, a compound derived
from a plant native to Western Samoa.
Whole
story
Fall
2000
Achy
Breaky HAART
by Linda Grinberg—
Structured Treatment Interruptions (STIs) are discussed
by Linda Grinberg, President of the Foundation for AIDS
& Immune Research and a member of the Board of Directors
of Project Inform.Whole
story
Spring
2000
AVN,
a potentially serious bone disorder. Is the incidence
rising in HIV+ people?—
Whole
story
Winter
1999/2000
HIV
vaccine development—
The hurdles faced by scientists.
Whole
story
Fall
1999
Natural immunity to
HIV?—
Understanding the reasons why some
individuals exposed to HIV remain uninfected should
shed light on the nature of protective immunity against
HIV.
Whole
story
Drug
Resistance Profiles in Tissues—
Study Results presented at the 3rd International Workshop
on HIV Drug Resistance and Treatment Strategies in San
Diego.
Whole
story
Summer
1999
Acupuncture for Treating Neuropathy—
Making sense of the science: acupuncture
therapy was recently evaluated in a large, randomized
placebo-controlled clinical trial.
Whole
story
HIV
Neuropathies—
Several disorders, no proven treatments.
Whole
story
Spring
1999
Mucosal biopsy study results
presented in Chicago—
AIDS Research Alliance collaborative
effort bears fruit Abstract presented at the 6th Conference
on Retroviruses and Opportunistic Infection in Chicago.
Whole
story
Is
Sterilizing Immunity Necessary to Prevent HIV Disease?—
Interview
with Bob Gallo.
Dr. Robert Gallo is co-discoverer of the HIV virus and
Director of the Institute of Human Virology in Baltimore,
MD.
Whole story
Is
Sterilizing Immunity Necessary to Prevent HIV Disease?—
Interview with Neal Nathanson.
Dr. Neal Nathanson is the Director of the Office of
AIDS Research, the office responsible for setting the
scientific agenda for AIDS research at the National
Institutes of Health.
Whole
story
Winter
1998/1999
The Gut Reaction to HIV—
Gut tissue is uniquely vulnerable
to HIV, and careful investigation of the gut is likely
to provide valuable clues to the pathology underlying
HIV infection.
Whole
story
XQ-9302
Study Report—
Report on a Phase I/II study evaluating a compound comprised
of twenty (20) uncharacterized Chinese botanicals in
HIV-1 infected individuals .
Whole
story
Summer/Fall
1998
Clinical Trials to Clinical
Reality—
"Bridging the gap" between science
and the patient.
Whole
story
|
